ING THINK
China: the next Pfizer will be Chinese
From the original
CHINA: China has rapidly become a leading hub for new innovative medicines, overtaking Europe and nearing the US. The country has become an innovation engine particularly in therapeutic areas such as oncology, immunology, antibody–drug conjugates (ADCs), bispecifics and cell/gene